Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Cash-and-Short-Term-Investments" stands at 739.68 Billion Japanese Yens as of 09/30/2025.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Cash and Short Term Investments" stands at 739.68 Billion JPY. This represents an increase of 111.33 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -13.89 percent compared to the value the year prior.
The 1 year change in percent is -13.89.
The 3 year change in percent is -7.32.
The 5 year change in percent is 17.25.
The 10 year change in percent is 10.80.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash and Short Term Investments | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash and Short Term Investments | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash and Short Term Investments | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash and Short Term Investments | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash and Short Term Investments | 280,205,508,085.11 |